Image

A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

Researching Codrituzumab for kids/teens with hard-to-treat solid tumors.

Recruiting
1-21 years
All
Phase 1
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is looking at a treatment called *codrituzumab* for kids and young adults who have solid tumors. *Solid tumors* are lumps of cancer cells, and *codrituzumab* is a medicine researchers want to test for safety and side effects. The study will also explore how the body handles this medicine. Participants need to be between 1 and 21 years old and have a tumor that didn’t respond to regular treatments or came back after treatment. It's important that their tumor makes a protein called *GPC3*. This protein will be checked before joining the full study.

  • *Study Length*: You might be in this study for a while, including visits to the hospital or clinic.
  • *Risks*: There could be side effects from the treatment, which the doctors will monitor closely.
  • *Eligibility*: Participants must not be on other cancer treatments or have certain health issues.
Print
Study details
    Primary Extra-cranial Solid Tumor
    Recurrent or Refractory Glypican 3 (GPC3)

NCT04928677

Memorial Sloan Kettering Cancer Center

5 July 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.